AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update.
AIM Vaccine Co., Ltd. has announced the successful approval of all resolutions at its Annual General Meeting held on May 20, 2024. Shareholders showed overwhelming support, with nearly 100% voting in favor of key reports and financial statements for the year 2023, and granted the Board mandates to issue new shares and repurchase existing shares. The high attendance rate of approximately 90% of total issued shares underscores strong shareholder engagement and confidence in the company’s direction.
For further insights into HK:6660 stock, check out TipRanks’ Stock Analysis page.
